BRVE insider buying
Every open-market purchase of Braveheart Bio, Inc. (BRVE) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$159.03M
Insiders buying (12m)10
Purchases on record10
Last purchase filedAug 11, 2026
In the last 12 months, 10 insiders of Braveheart Bio, Inc. bought $159.03M of BRVE stock on the open market in 10 reported purchases. The most recent was filed on Aug 11, 2026: Andreessen Marc L +3 (10% Owner) bought 1,100,000 shares at $18.00, worth $19.80M. The largest purchase on record here is $64.80M by Forbion Growth Opportunities Fund III Cooperatief U.A. +3 on Aug 7, 2026.
Get the next BRVE insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll BRVE insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Aug 11 | Andreessen Marc L +310% Owner | $19.80M | 1,100,000 | $18.00 | +12% | Aug 7 | SEC |
| Aug 11 | Chimovits ErezDirector, 10% Owner | $34.92M | 1,940,000 | $18.00 | new | Aug 7 | SEC |
| Aug 11 | OrbiMed Genesis GP LLC +2Director, 10% Owner | $34.92M | 1,940,000 | $18.00 | new | Aug 7 | SEC |
| Aug 7 | Rickey James PaulChief Financial Officer | $499.99K | 27,777 | $18.00 | +6% | Aug 7 | SEC |
| Aug 7 | Viehbacher ChristopherDirector | $1.50M | 83,333 | $18.00 | +16% | Aug 7 | SEC |
| Aug 7 | Malek David IDirector | $74.99K | 4,166 | $18.00 | +1% | Aug 7 | SEC |
| Aug 7 | Anderson Michele A.Chief Development Officer | $20K | 1,111 | $18.00 | +0% | Aug 7 | SEC |
| Aug 7 | Murdoch TravisCEO and President, Director | $1.50M | 83,333 | $18.00 | +3% | Aug 7 | SEC |
| Aug 7 | Lubner David CharlesDirector | $999.99K | 55,555 | $18.00 | new | Aug 7 | SEC |
| Aug 7 | Forbion Growth Opportunities…10% Owner | $64.80M | 3,600,000 | $18.00 | +45% | Aug 7 | SEC |